Displaying items tagged: Tetra Therapeutics
Michigan Capital Network aims to raise $25M for fourth VC fund
GRAND RAPIDS — Michigan Capital Network plans to form a fourth venture capital fund.
Tetra Therapeutics CEO Mark Gurney retires
EAST GRAND RAPIDS —Mark Gurney retired as CEO of drug developer Tetra Therapeutics Inc. at the end of June, more than a year after selling the company to Japan-based pharmaceutical company Shionogi & Co. Ltd.
Tetra Therapeutics’ Shionogi deal builds resources of large pharmaceutical company
After years of raising millions in capital and federal grant funding for Tetra Therapeutics Inc. — which was developing a new drug that could potentially treat Alzheimer’s disease and a form of autism — Mark Gurney in 2020 finally found the big money he needed to get to the end.
‘TREMENDOUS WIN:’ Tetra Therapeutics’ sale offers healthy returns for investors, validation for local ecosystem
GRAND RAPIDS — Tetra Therapeutics Inc.’s sale to a Japanese pharmaceutical company provides a final pathway toward bringing to market potential new drugs to treat Alzheimer’s disease and a form of autism, as well as generates a handsome return for financial backers.
Grand Rapids drug developer sells to Japan-based pharma company in potential $500M deal
GRAND RAPIDS — Drug developer Tetra Therapeutics Inc. has reached a definitive merger agreement with Japan-based pharmaceutical company Shionogi & Co. Ltd. in a deal that could reach $500 million.
MiBiz Growth Report: March 15, 2020
MiBiz Growth Report for March 15, 2020.
Drug developer secures new investment from Japanese firm, outlines path to buyout
GRAND RAPIDS — Drug developer Tetra Therapeutics has secured a new equity investment from Japanese pharmaceutical company Shionogi & Co. Ltd.
Growth Report: Sept. 28,2019
Growth report for Sept. 28, 2019.
Drug developer’s clinical trial enrollment going faster than expected
GRAND RAPIDS — Tetra Therapeutics says it is enrolling patients faster than expected for a clinical trial on a potential new drug to treat Alzheimer’s disease.